|
Market Closed -
Nasdaq
16:00:00 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 87.90 USD | -0.90% |
|
-1.50% | +32.40% |
| Market Cap | 12.42B 10.72B 10.09B 9.17B 17.25B 1,190B 17.5B 118B 46.38B 595B 46.62B 45.6B 1,982B | P/E 2026 * |
-24.8x | P/E 2027 * | -18.9x |
|---|---|---|---|---|---|
| Enterprise Value | 11.58B 10.01B 9.41B 8.56B 16.09B 1,110B 16.33B 110B 43.27B 555B 43.49B 42.55B 1,849B | EV / Sales 2026 * |
25x | EV / Sales 2027 * | 34.6x |
| Free-Float |
94.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Arrowhead Pharmaceuticals, Inc.
| 1 day | -0.90% | ||
| 1 week | -1.50% | ||
| Current month | +3.84% | ||
| 1 month | +18.30% | ||
| 3 months | +18.86% | ||
| 6 months | +36.53% | ||
| Current year | +32.40% |
| 1 week | 83.78 |  | 88.94 |
| 1 month | 71 | | 95.49 |
| Current year | 54.02 | | 95.49 |
| 1 year | 19.56 | | 95.49 |
| 3 years | 9.57 | | 95.49 |
| 5 years | 9.57 | | 95.49 |
| 10 years | 1.2 | | 95.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2007-11-30 | |
Daniel Apel
DFI | Director of Finance/CFO | - | 2025-05-12 |
Peter Carignan
CTO | Chief Tech/Sci/R&D Officer | - | 2022-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 56 | - | |
Mauro Ferrari
BRD | Director/Board Member | 66 | 2010-08-18 |
Michael Perry
BRD | Director/Board Member | 66 | 2011-12-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/15/26 | Free | Director | 11,882 | 0.0084% | ||
| 3/5/26 | Sell | Chief Technology Officer | 10,000 | 0.0071% | ||
| 1/6/26 | Don | Chief Operating Officer | 77,500 | 0.0571% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.90% | -1.50% | +341.49% | +211.04% | 12.53B | |
| +0.17% | +3.62% | +70.94% | +109.68% | 73.25B | |
| +1.73% | +16.15% | +51.73% | +93.89% | 61.95B | |
| +0.11% | -3.10% | +0.94% | +491.16% | 28.02B | |
| +5.24% | +5.65% | +56.71% | +21.30% | 24.15B | |
| +1.26% | -0.05% | -17.59% | -15.96% | 23.01B | |
| -0.71% | +5.26% | +241.94% | +427.03% | 18.35B | |
| 0.00% | +5.57% | +39.57% | -14.30% | 19.46B | |
| +3.83% | +2.65% | +21.42% | +557.58% | 15.92B | |
| +1.53% | +3.49% | +40.68% | +151.75% | 12.96B | |
| Average | +1.23% | +1.16% | +84.78% | +203.32% | 28.96B | |
| Weighted average by Cap. | +1.16% | +3.30% | +68.19% | +168.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 463M 400M 376M 342M 643M 44.32B 652M 4.41B 1.73B 22.17B 1.74B 1.7B 73.84B | 339M 293M 276M 251M 472M 32.52B 478M 3.24B 1.27B 16.27B 1.27B 1.25B 54.18B |
| Net income | -504M -435M -410M -372M -700M -48.29B -710M -4.8B -1.88B -24.15B -1.89B -1.85B -80.45B | -655M -566M -532M -484M -910M -62.76B -923M -6.24B -2.45B -31.39B -2.46B -2.41B -105B |
| Net Debt | -832M -719M -676M -615M -1.16B -79.75B -1.17B -7.93B -3.11B -39.89B -3.13B -3.06B -133B | -683M -590M -555M -504M -948M -65.42B -962M -6.51B -2.55B -32.72B -2.56B -2.51B -109B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-18 | US$87.90 | -0.90% | 972,091 |
| 26-08-17 | US$88.70 | +2.38% | 930,066 |
| 26-08-14 | US$86.64 | +1.23% | 818,161 |
| 26-08-13 | US$85.59 | -1.90% | 1,101,911 |
| 26-08-12 | US$87.25 | -2.23% | 1,119,664 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ARWR Stock
Select your edition
All financial news and data tailored to specific country editions
